The Emerging Functions of LRRK2 and Rab GTPases in the Endolysosomal System

Overview

Journal Front Neurosci

Date 2020 Apr 8

PMID 32256311

Citations 30

Authors

Tomoki Kuwahara

Takeshi Iwatsubo

Affiliations

Soon will be listed here.

Abstract

The leucine-rich repeat kinase 2 (), the most common causative gene for autosomal-dominant familial Parkinson's disease, encodes a large protein kinase harboring multiple characteristic domains. LRRK2 phosphorylates a set of Rab GTPases in cells, which is enhanced by the Parkinson-associated LRRK2 mutations. Accumulating evidence suggests that LRRK2 regulates intracellular vesicle trafficking and organelle maintenance including Golgi, endosomes and lysosomes. Furthermore, genetic knockout or inhibition of LRRK2 cause lysosomal abnormalities in rodents and primates, and cells from Parkinson's patients with LRRK2 mutations also exhibit altered lysosome morphology. Cell biological studies on LRRK2 in a diverse cellular context further strengthen the potential connection between LRRK2 and regulation of the endolysosomal system, part of which is mediated by Rab phosphorylation by LRRK2. We will focus on the latest advances on the role of LRRK2 and Rab in relation to the endolysosomal system, and discuss the possible link to the pathomechanism of Parkinson's disease.

Citing Articles

Salmonella exploits LRRK2-dependent plasma membrane dynamics to invade host cells.

Zhu H, Sydor A, Yan B, Li R, Boniecki M, Lyons C Nat Commun. 2025; 16(1):2329.

PMID: 40057496 PMC: 11890592. DOI: 10.1038/s41467-025-57453-x.

Role of Dardarin and Isthmin-1 in the Protective Effect of Hydroxytyrosol Against Corn Syrup-Induced Liver Damage.

Onat E, Kocaman N, Hancer S, Yildirim M Cureus. 2025; 17(1):e76803.

PMID: 39897276 PMC: 11787043. DOI: 10.7759/cureus.76803.

CK and LRRK2 Involvement in Neurodegenerative Diseases.

Bova V, Mannino D, Capra A, Lanza M, Palermo N, Filippone A Int J Mol Sci. 2024; 25(21).

PMID: 39519213 PMC: 11546471. DOI: 10.3390/ijms252111661.

How Parkinson's Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types.

Bailey H, Cookson M J Parkinsons Dis. 2024; 14(7):1331-1352.

PMID: 38905056 PMC: 11492021. DOI: 10.3233/JPD-230432.

Lysosomal stress drives the release of pathogenic α-synuclein from macrophage lineage cells via the LRRK2-Rab10 pathway.

Abe T, Kuwahara T, Suenaga S, Sakurai M, Takatori S, Iwatsubo T iScience. 2024; 27(2):108893.

PMID: 38313055 PMC: 10835446. DOI: 10.1016/j.isci.2024.108893.

References

Reczek D, Schwake M, Schroder J, Hughes H, Blanz J, Jin X . LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell. 2007; 131(4):770-83. DOI: 10.1016/j.cell.2007.10.018. View

Baptista M, Dave K, Frasier M, Sherer T, Greeley M, Beck M . Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs. PLoS One. 2013; 8(11):e80705. PMC: 3828242. DOI: 10.1371/journal.pone.0080705. View

Boddu R, Hull T, Bolisetty S, Hu X, Moehle M, Daher J . Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury. Hum Mol Genet. 2015; 24(14):4078-93. PMC: 4476452. DOI: 10.1093/hmg/ddv147. View

Maekawa T, Kubo M, Yokoyama I, Ohta E, Obata F . Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen. Biochem Biophys Res Commun. 2010; 392(3):431-5. DOI: 10.1016/j.bbrc.2010.01.041. View

Vilarino-Guell C, Wider C, Ross O, Dachsel J, Kachergus J, Lincoln S . VPS35 mutations in Parkinson disease. Am J Hum Genet. 2011; 89(1):162-7. PMC: 3135796. DOI: 10.1016/j.ajhg.2011.06.001. View

Higashi S, Moore D, Yamamoto R, Minegishi M, Sato K, Togo T . Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease. J Neuropathol Exp Neurol. 2009; 68(9):994-1005. PMC: 2768772. DOI: 10.1097/NEN.0b013e3181b44ed8. View

Eguchi T, Kuwahara T, Sakurai M, Komori T, Fujimoto T, Ito G . LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis. Proc Natl Acad Sci U S A. 2018; 115(39):E9115-E9124. PMC: 6166828. DOI: 10.1073/pnas.1812196115. View

Desplats P, Lee H, Bae E, Patrick C, Rockenstein E, Crews L . Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A. 2009; 106(31):13010-5. PMC: 2722313. DOI: 10.1073/pnas.0903691106. View

Fan Y, Howden A, Sarhan A, Lis P, Ito G, Martinez T . Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils. Biochem J. 2017; 475(1):23-44. PMC: 5748842. DOI: 10.1042/BCJ20170803. View

10.

Schapansky J, Nardozzi J, Felizia F, LaVoie M . Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy. Hum Mol Genet. 2014; 23(16):4201-14. PMC: 4103671. DOI: 10.1093/hmg/ddu138. View

11.

Bosgraaf L, van Haastert P . Roc, a Ras/GTPase domain in complex proteins. Biochim Biophys Acta. 2003; 1643(1-3):5-10. DOI: 10.1016/j.bbamcr.2003.08.008. View

12.

Pihlstrom L, Rengmark A, Bjornara K, Dizdar N, Fardell C, Forsgren L . Fine mapping and resequencing of the PARK16 locus in Parkinson's disease. J Hum Genet. 2015; 60(7):357-62. DOI: 10.1038/jhg.2015.34. View

13.

Vidyadhara D, Lee J, Chandra S . Role of the endolysosomal system in Parkinson's disease. J Neurochem. 2019; 150(5):487-506. PMC: 6707858. DOI: 10.1111/jnc.14820. View

14.

Blauwendraat C, Heilbron K, Vallerga C, Bandres-Ciga S, von Coelln R, Pihlstrom L . Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms. Mov Disord. 2019; 34(6):866-875. PMC: 6579628. DOI: 10.1002/mds.27659. View

15.

MacLeod D, Rhinn H, Kuwahara T, Zolin A, Paolo G, McCabe B . RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron. 2013; 77(3):425-39. PMC: 3646583. DOI: 10.1016/j.neuron.2012.11.033. View

16.

Chiu C, Yeh T, Lai S, Weng Y, Huang Y, Cheng Y . Increased Rab35 expression is a potential biomarker and implicated in the pathogenesis of Parkinson's disease. Oncotarget. 2016; 7(34):54215-54227. PMC: 5342336. DOI: 10.18632/oncotarget.11090. View

17.

Biskup S, Moore D, Celsi F, Higashi S, West A, Andrabi S . Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol. 2006; 60(5):557-569. DOI: 10.1002/ana.21019. View

18.

Lawrence R, Zoncu R . The lysosome as a cellular centre for signalling, metabolism and quality control. Nat Cell Biol. 2019; 21(2):133-142. DOI: 10.1038/s41556-018-0244-7. View

19.

Yu M, Arshad M, Wang W, Zhao D, Xu L, Zhou L . LRRK2 mediated Rab8a phosphorylation promotes lipid storage. Lipids Health Dis. 2018; 17(1):34. PMC: 5828482. DOI: 10.1186/s12944-018-0684-x. View

20.

Cuervo A, Dice J . When lysosomes get old. Exp Gerontol. 2000; 35(2):119-31. DOI: 10.1016/s0531-5565(00)00075-9. View